JAK2 and essential thrombocythemia: In addition to JAK2 (Janus kinase 2), MPL plays a significant role in the pathogenesis of myeloproliferative neoplasms (MPN), particularly in essential thrombocythemia (ET) and myelofibrosis (MF) (68).